Purchase Order 75N90026P00037
- Not listed
- The National Institutes of Health Clinical Center awarded a $25,395 firm fixed-price purchase order to Neuropace Inc. for the procurement of critical supplies to support scheduled surgical cases. The contract, which carries an ultimate completion date of September 16, 2026, was awarded on September 15, 2025, without a set-aside designation. Neuropace Inc., a Mountain View, California-based medical device manufacturer specializing in implantable neurostimulation systems, will perform work at...
- The National Institutes of Health Clinical Center has awarded a purchase order valued at $18,995 to Neuropace Inc. for neuropace electrodes. The contract, issued on November 6, 2025, with a completion date of December 5, 2025, is structured as a firm fixed-price purchase order without set-aside designation. Neuropace Inc., a Mountain View, California-based medical device manufacturer specializing in implantable neurostimulation systems, will supply the electrodes to support the NIH Clinical...
- This federal contract award, valued at $60,325.00, was issued by the National Institutes of Health (NIH) Clinical Center to Neuropace Inc., a medical device manufacturer based in Mountain View, California. The contract is for the provision of electrodes and accessories to support upcoming surgeries scheduled for October 14, 2025 and October 17, 2025. The contract is a firm fixed-price purchase order with a completion date of September 30, 2025. This award was made on a full and open...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Neuropace Inc., a medical device manufacturer based in Mountain View, California. The $16,005.00 contract is for the procurement of electrodes and accessories for neurosurgery. The award has a completion date of September 17, 2025 and was not set aside for any specific business type. Neuropace has a history of securing federal contract awards from the Department of Veterans Affairs (VA)...
- This is a $27,480 firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Neuropace Inc., a medical device manufacturer based in Mountain View, California. The contract is for the emergency procurement of electrodes and accessories, with a completion date of June 10, 2025. The contract was awarded on a full and open competition basis without any set-aside designation. Neuropace specializes in implantable neurostimulation systems,...
- Neuropace Inc., a Mountain View, California-based medical device manufacturer specializing in implantable neurostimulation systems, was awarded a firm fixed-price purchase order on December 17, 2025, by Veterans Integrated Service Network 22 (VISN 22) of the Department of Veterans Affairs. The contract, valued at $37,600, calls for the delivery of a prosthetics neurostimulator implant and is scheduled for completion by January 31, 2026. No set-aside designation was used in this full and open...
- Neuropace, Inc. has been awarded a $55,695 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to supply an implant for a veteran. As a manufacturer of medical devices specializing in implantable products for neurological disorders, Neuropace will deliver its goods and services under this contract to support veterans' healthcare needs at the place of performance in Mountain View, California. No small...
- The U.S. Department of Veterans Affairs (VA) awarded a $45,640.00 firm-fixed-price purchase order to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems. The contract is for the delivery of surgical implants, specifically neurostimulators and related devices, to be used in the treatment of neurological disorders, particularly epilepsy, for veterans. The contract has an ultimate completion date of December 6, 2024. Neuropace Inc. has a history of...
- This is a $45,640 firm-fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems for treating neurological disorders. The contract is for the delivery of surgical implants, likely Neuropace's RNS System, a responsive neurostimulation device for treating focal onset seizures in individuals with epilepsy. The contract is part of Neuropace's ongoing work to supply...
- This $43,900 firm-fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Neuropace Inc., a medical device manufacturer specializing in implantable neurostimulation systems. The contract is for the delivery of surgical implants, specifically Neuropace's RNS System, a responsive neurostimulation device for treating focal onset seizures in individuals with epilepsy. The contract has an ultimate completion date of November 27, 2023, and is part of the VA's...
Neuropace Inc., a Mountain View, California-based medical device manufacturer specializing in implantable neurostimulation systems for neurological disorders, was awarded a $115,286.25 firm fixed-price purchase order by the National Institutes of Health Clinical Center on December 30, 2025. The contract, which carries an ultimate completion date of December 29, 2026, represents a direct procurement with no set-aside designation. Based on Neuropace's established federal contracting history, this purchase order likely involves the supply of neurostimulation devices, surgical implants, electrodes, and related accessories to support clinical operations at the NIH Clinical Center. The award aligns with Neuropace's core competency in providing specialized medical devices for treating seizure disorders and other neurological conditions. The company has maintained an established relationship with federal health agencies, particularly through prior contracts with the Department of Veterans Affairs and ongoing collaboration with the National Institute of Neurological Disorders and Stroke on advanced research initiatives focused on responsive neurostimulation therapies. This purchase order supports the Clinical Center's procurement needs while leveraging Neuropace's expertise in developing and delivering innovative neurostimulation technologies to federal medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $115.3k | 12/30/25 |